Cynapsus Thera Cm Sh (CYNA)
40.48 +0.01 (+0.02%) 10/20/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,526 | -9,803 | -4,300 | -3,060 | 0 |
| Depreciation Amortization | 135 | 68 | 50 | 60 | 0 |
| Other Working Capital | 1,222 | 339 | 610 | 450 | 0 |
| Other Operating Activity | -5,063 | 343 | -420 | 1,220 | 0 |
| Operating Cash Flow | $-25,232 | $-9,053 | $-4,060 | $-1,330 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -339 | -236 | -10 | 0 | 0 |
| Investing Cash Flow | $-339 | $-236 | $-10 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 91,580 | 24,355 | 0 | 0 | 0 |
| Other Financing Activity | -7,494 | -1,957 | 6,240 | 1,090 | 0 |
| Financing Cash Flow | $84,086 | $22,398 | $6,240 | $1,090 | $0 |
| Exchange Rate Effect | 10,021 | 627 | 0 | 0 | 0 |
| Beginning Cash Position | 13,673 | 2,074 | 40 | 290 | 0 |
| End Cash Position | 82,209 | 15,810 | 2,220 | 50 | 0 |
| Net Cash Flow | $68,536 | $13,736 | $2,170 | $-240 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,232 | -9,053 | -4,060 | -1,330 | 0 |
| Capital Expenditure | -339 | -236 | 0 | 0 | 0 |
| Free Cash Flow | -25,571 | -9,289 | -4,060 | -1,330 | 0 |